about
Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunitiesTreatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampinProgrammatic Management of Drug-Resistant Tuberculosis: An Updated Research AgendaThe epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection.Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum cultureEighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmissionBaseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.Risk factors for nonadherence with Pap testing in HIV-infected women.Revisiting rates of reactivation tuberculosis: a population-based approachInterferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire.Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in TanzaniaIntegration of a participatory research strategy into a rural health surveyHigh incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workersRecent cigarette smoking and HIV disease progression: no evidence of an association.Diabetes, glycemic control, and risk of tuberculosis: a population-based case-control study.Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosisEffectiveness of reporting on latent tuberculous infection in Massachusetts, 2006-2008Sustained reduction in tuberculosis incidence following a community-based participatory interventionMarginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosisRecent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems.Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men.Prevention of tuberculosis in older adults in the United States: obstacles and opportunities.Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer diseaseGreater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis.Developing a predictive risk model for first-line antiretroviral therapy failure in South AfricaEndothelial function in HIV-infected persons.Principles for designing future regimens for multidrug-resistant tuberculosis.Clinical practice. Latent tuberculosis infection in the United States.Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis.A large, simple trial of a tuberculosis vaccine.Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention.Predictors of delayed care seeking for tuberculosis in southern India: an observational study.Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.Latent Tuberculosis Infection Testing Practices in Long-Term Care Facilities, Boston, Massachusetts.Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
P50
Q28072376-A027E9CC-08E6-4E2A-8B7D-815001B9CBD1Q28265640-22370097-E76E-4AEA-AC9B-EF24ECA2DA3DQ28552438-7F4C5A14-6FEC-4C7D-816F-44D61DDDFAF6Q30235074-41EEB6A3-1482-4D00-BAFC-ECB65E3E1678Q31026796-4DE2AB2C-1FF8-4796-B027-FB796F6D6B4DQ31041310-56C709E4-BDAE-4330-BAA0-F5B3D1D14AD4Q33322950-2F53FD35-9628-4F21-87F4-303AE7058D0CQ33825807-789431F7-A832-42BF-A947-31922D5986EEQ33854478-65A9444F-7296-4080-B101-F114D3F887AAQ34006364-FA1443F0-F61A-4A3B-9E13-2501DE9662A2Q34065641-B74ECB01-9244-4372-9D17-699B6F1F63A8Q34137874-49658406-54CA-4098-9C34-84D35CAA4139Q34307010-233D6C15-A7FF-434D-8B0B-D6025064EDB6Q34312118-C9CF9A5A-7E85-45E2-A6F3-6F32B15D3734Q34742007-F9DF88D4-D4D0-48DF-8FE0-07811A420ED1Q34779982-D3B7B6AF-7F0B-457F-816F-321DA8D623D3Q35115686-F55CF5CD-2D5A-4C64-90F2-B994F2B27667Q35563666-B3B6C6DA-06DD-46AE-85B0-27AF5E9B7F41Q35654015-B57414DF-7146-44A6-8E9A-3B71FCC0E051Q35771345-6B4286C0-E002-4A4A-86A0-35EC9E28ADFEQ35775657-9721027A-13FE-4ABD-BF88-92C10137821EQ35953581-43ADA255-F8E8-4065-9F87-03E35F02BB87Q36109276-A1138724-E047-41E5-80E4-91C9D835F21BQ36457649-D2D23D8D-C067-46FA-BCC3-D8BD03BA999CQ36468227-79D22945-390B-4B19-86CE-DE81C253C523Q36650557-EF5734AB-6695-4ABB-A345-AEC2A5421EE6Q36956921-C3EB171C-08BE-4963-BA0A-E3A0AE359579Q37093875-4B53E80F-388E-4400-9904-DD45549BDC27Q37247486-3D16A7BD-C5B9-4C20-856A-F982D03A0AF0Q37290134-C60989D6-E62F-4B1E-BB63-BBCACCF4FB42Q37331905-4FBBAA21-F439-4A84-9897-F53308F6827CQ37398037-8A0ACEBD-3D47-46A2-962C-EDFE9399A053Q37864650-2A645717-FA59-4F9C-ACA8-4FF329B2ED62Q38065021-21BCB1FC-C8A6-418C-9109-725CB12B2F80Q38473751-8E4F71E3-439B-45BE-AE20-6E7E8E5AA94DQ38612573-2AAC3B2B-9C66-41FB-8D49-B4D0BFB607EBQ38625570-E3D0424A-F0AF-4F57-B6D2-D249B3A9681DQ38674895-2FE5BD9E-8232-4EEA-A100-136965C7BB77Q38807032-40834131-0BBF-4A3E-86E1-6D063E48518AQ39014202-D67769A4-8AE1-46EF-8A4D-C41EB0A874FB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
C. Horsburgh
@ast
C. Horsburgh
@en
C. Horsburgh
@es
C. Horsburgh
@nl
C. Horsburgh
@sl
type
label
C. Horsburgh
@ast
C. Horsburgh
@en
C. Horsburgh
@es
C. Horsburgh
@nl
C. Horsburgh
@sl
prefLabel
C. Horsburgh
@ast
C. Horsburgh
@en
C. Horsburgh
@es
C. Horsburgh
@nl
C. Horsburgh
@sl
P106
P31
P496
0000-0001-6838-7895